Showing results (1-10 of 524) with videos related to
Sort By:
Pageof 53
Biomedicines|October 23, 2021
Inhaled Corticosteroids and the Lung Microbiome in COPDHolly R Keir, Marco Contoli, James D ChalmersEuropean Respiratory Review : an Official Journal of the European Respiratory Society|February 24, 2022
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapyHolly R Keir, James D ChalmersSeminars in Respiratory and Critical Care Medicine|July 14, 2021
Pathophysiology of BronchiectasisHolly R Keir, James D ChalmersRespirology (Carlton, Vic.)|June 29, 2017
The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Simon Finch, Holly R Keir, Alison J Dicker, et al.Expert Review of Molecular Diagnostics|September 1, 2017
Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory diseaseHolly R Keir, Christopher J Fong, Alison J Dicker, et al.ERJ Open Research|June 17, 2025
Short-term stability of the sputum microbiota in bronchiectasis and cystic fibrosisHollian Richardson, Holly R Keir, Sandrine Nitza, et al.ERJ Open Research|December 2, 2020
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixinHolly R Keir, Hollian Richardson, Christina Fillmore, et al.American Journal of Respiratory and Critical Care Medicine|May 22, 2019
Airway Bacterial Load and Inhaled Antibiotic Response in BronchiectasisOriol Sibila, Elena Laserna, Amelia Shoemark, et al.The Lancet. Respiratory Medicine|May 7, 2021
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational studyAlison J Dicker, Mike Lonergan, Holly R Keir, et al.Respiratory Research|July 3, 2020
Blood neutrophil counts are associated with exacerbation frequency and mortality in COPDMike Lonergan, Alison J Dicker, Megan L Crichton, et al.Pageof 53